Astellas Pharma Inc. (FRA:YPH)

Astellas Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 8, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	21,787	15,998	18,058	23,412	26,092	24,354
Market Cap Growth	23.59%	-11.41%	-22.87%	-10.27%	7.14%	-7.27%
Enterprise Value	24,253	20,542	21,852	20,799	23,501	22,002
Last Close Price	11.95	8.55	9.10	11.49	12.08	10.99
PE Ratio	30.30	51.03	172.88	34.26	28.37	26.22
PS Ratio	1.89	1.35	1.84	2.23	2.72	2.53
PB Ratio	2.35	1.71	1.85	2.24	2.41	2.28
P/TBV Ratio	23.90	-	-	5.48	6.59	7.02
P/FCF Ratio	10.33	16.44	21.92	11.61	15.53	11.48
P/OCF Ratio	9.46	13.31	17.09	10.32	13.67	10.30
EV/Sales Ratio	2.22	1.74	2.22	1.98	2.45	2.29
EV/EBITDA Ratio	7.97	7.19	12.63	8.90	10.64	8.83
EV/EBIT Ratio	12.19	12.62	28.62	12.97	14.53	11.38
EV/FCF Ratio	11.50	21.11	26.53	10.31	13.98	10.37
Debt / Equity Ratio	0.46	0.62	0.63	0.14	0.15	0.20
Debt / EBITDA Ratio	1.32	2.03	3.57	0.61	0.72	0.86
Debt / FCF Ratio	2.02	5.95	7.50	0.70	0.94	1.01
Asset Turnover	0.58	0.55	0.53	0.63	0.56	0.54
Inventory Turnover	1.32	1.28	1.38	1.76	1.60	1.56
Quick Ratio	0.76	0.79	0.69	1.13	1.05	1.15
Current Ratio	1.03	1.13	0.93	1.45	1.34	1.47
Return on Equity (ROE)	7.95%	3.26%	1.10%	6.65%	8.72%	9.01%
Return on Assets (ROA)	6.68%	4.77%	2.58%	6.05%	5.92%	6.83%
Return on Capital (ROIC)	9.58%	6.52%	3.61%	8.55%	8.17%	9.31%
Return on Capital Employed (ROCE)	17.40%	11.60%	5.50%	13.40%	13.30%	14.90%
Earnings Yield	3.30%	1.96%	0.58%	2.92%	3.52%	3.81%
FCF Yield	9.68%	6.08%	4.56%	8.62%	6.44%	8.71%
Dividend Yield	3.77%	5.35%	4.71%	3.62%	3.07%	2.94%
Payout Ratio	106.09%	254.19%	684.38%	101.66%	68.69%	63.15%
Buyback Yield / Dilution	0.07%	0.14%	1.39%	1.38%	0.41%	1.03%
Total Shareholder Return	3.84%	5.49%	6.11%	5.00%	3.48%	3.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.